Eosinophilia-myalgia syndrome. Recognition of a distinct clinicopathologic entity.
The eosinophilia-myalgia syndrome is a newly described disorder related to the ingestion of L-tryptophan-containing products. Its presentation may mimic other disorders characterized by eosinophilia and muscle pain and/or weakness, but can be differentiated by certain characteristic laboratory and pathologic findings. We report two such cases, describe their features, and review similar syndromes.
Gibbons
R B
RB
Department of Medicine, St Joseph Hospital, Denver, CO 80218.
Metzger
J R
JR
D003120:Colorado / Q000453:epidemiology; D003937:Diagnosis, Differential; D004802:Eosinophilia / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D012651:Self Medication; D013577:Syndrome; D014364:Tryptophan / Q000008:administration & dosage / Q000009:adverse effects*
D014364:Tryptophan